Skip to content
Slotex Central UK

Zimbabwe Declines ‘Lopsided’ American Health Aid Deal Over Information Fears

Medical aid illustration
The proposed US funding was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a substantial US health deal valued at $367m (272 million pounds) spanning five years because of Washington's insistence on sensitive biological samples.

This rejection came to light following a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the agreement was "skewed".

A government representative has since explained that the US was requesting health data for research and commercial gain while was unwilling to share the benefits from future treatments.

"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has appealed for more negotiations to secure a deal acceptable to all parties so the nation's critical HIV treatment initiative can proceed.

Wider Implications

This rejection comes after a comparable situation in Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the security of Kenyans' medical information.

After returning to office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.

Based on statements, 16 African countries have so far agreed to these new health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Rejected Agreement

The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded initiatives," the Ambassador said.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Our nation was requested to provide its biological resources and data for a long time, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our population if a future disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining frameworks already set up via the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.

"This framework is intended to ensure that when a nation contributes its information, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the funds to develop them."

The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.

"We are open to further discussions with our American counterparts on how subsequent collaboration might be arranged in a way that respects the sovereignty and interests of each country."

Health Experts Response

A leading public health body expressed it recognised the government's concerns, but urged that talks should continue considering much of the nation's HIV programmes depended on foreign aid.

"Where technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.

The situation highlights the continuing debate between accepting crucial international aid and safeguarding a country's data in an increasingly interconnected world.

SH
Written by

Sarah Hill

A seasoned gambling analyst with over a decade of experience in reviewing online casinos and developing winning slot strategies.

Slotex Central UK

Type to search articles.